Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 26 10:12AM ET
7.99
Dollar change
+0.23
Percentage change
2.96
%
IndexRUT P/E44.91 EPS (ttm)0.18 Insider Own59.63% Shs Outstand47.43M Perf Week-4.20%
Market Cap378.97M Forward P/E4.23 EPS next Y1.89 Insider Trans0.00% Shs Float19.14M Perf Month-23.17%
Income8.43M PEG- EPS next Q0.30 Inst Own37.30% Short Float16.76% Perf Quarter-61.42%
Sales2.46B P/S0.15 EPS this Y-32.44% Inst Trans-1.96% Short Ratio8.70 Perf Half Y-61.88%
Book/sh12.62 P/B0.63 EPS next Y28.10% ROA0.39% Short Interest3.21M Perf Year-75.67%
Cash/sh3.67 P/C2.18 EPS next 5Y- ROE1.45% 52W Range7.73 - 36.70 Perf YTD-63.13%
Dividend Est.0.57 (7.16%) P/FCF4.93 EPS past 5Y-25.46% ROI0.50% 52W High-78.23% Beta1.05
Dividend TTM0.58 (7.26%) Quick Ratio1.61 Sales past 5Y10.19% Gross Margin17.27% 52W Low3.36% ATR (14)0.51
Dividend Ex-DateApr 02, 2024 Current Ratio1.61 EPS Y/Y TTM-91.81% Oper. Margin5.44% RSI (14)32.50 Volatility4.39% 5.85%
Employees60000 Debt/Eq1.89 Sales Y/Y TTM0.50% Profit Margin0.34% Recom2.43 Target Price15.30
Option/ShortYes / Yes LT Debt/Eq1.83 EPS Q/Q-144.18% Payout585.26% Rel Volume0.18 Prev Close7.76
Sales Surprise3.76% EPS Surprise-4.57% Sales Q/Q-5.25% EarningsMay 08 AMC Avg Volume368.73K Price7.99
SMA20-7.31% SMA50-31.45% SMA200-61.99% Trades Volume10,135 Change2.96%
Date Action Analyst Rating Change Price Target Change
Mar-19-24Initiated Guggenheim Sell $8
Mar-06-24Downgrade Canaccord Genuity Buy → Hold
Mar-04-24Downgrade Barrington Research Outperform → Mkt Perform
Nov-10-23Upgrade Barrington Research Mkt Perform → Outperform $18
Aug-14-23Upgrade Morgan Stanley Underweight → Equal-Weight $31
Mar-02-23Downgrade Barrington Research Outperform → Mkt Perform
Oct-10-22Downgrade BofA Securities Buy → Neutral $68 → $48
Apr-22-22Initiated Barrington Research Outperform $100
Jan-10-22Downgrade Morgan Stanley Equal-Weight → Underweight $100 → $90
Mar-05-21Downgrade Cowen Outperform → Market Perform $85 → $90
Apr-23-24 04:17PM
Apr-18-24 09:00AM
Apr-15-24 04:26PM
Apr-09-24 04:15PM
Apr-02-24 04:15PM
11:04AM Loading…
Mar-24-24 11:04AM
Mar-12-24 04:15PM
Mar-11-24 09:00AM
Mar-06-24 04:15PM
09:50AM
Mar-04-24 09:08AM
Mar-01-24 10:41PM
05:12PM
Feb-29-24 05:40PM
04:50PM
04:05PM Loading…
04:05PM
Feb-15-24 04:15PM
Feb-13-24 04:05PM
Jan-23-24 08:30AM
Jan-21-24 03:27PM
Dec-19-23 08:30AM
Dec-12-23 06:35AM
Dec-06-23 08:30AM
Nov-30-23 08:30AM
Nov-29-23 08:30AM
Nov-10-23 12:23PM
Nov-09-23 11:01PM
Nov-08-23 05:03PM
04:05PM
Nov-01-23 12:10PM
10:01AM Loading…
10:01AM
Oct-17-23 09:05AM
Oct-13-23 07:06AM
Oct-02-23 09:05AM
Sep-20-23 03:16PM
Sep-14-23 08:30AM
Sep-06-23 08:30AM
Aug-31-23 08:30AM
Aug-29-23 08:30AM
Aug-15-23 08:30AM
Aug-10-23 08:30AM
Aug-03-23 08:00PM
06:15PM
05:05PM
04:05PM
Jul-24-23 03:05PM
Jul-06-23 08:30AM
Jul-04-23 02:34PM
Jun-29-23 08:30AM
Jun-21-23 08:00PM
Jun-14-23 08:30AM
Jun-13-23 08:30AM
Jun-07-23 08:30AM
Jun-06-23 02:07PM
May-30-23 08:30AM
May-23-23 01:07PM
May-07-23 08:08AM
May-03-23 06:15PM
05:07PM
04:05PM
04:05PM
Apr-27-23 08:30AM
08:24AM
05:00AM
Apr-26-23 08:00PM
08:30AM
Apr-18-23 04:05PM
01:12PM
Apr-16-23 02:24PM
Apr-13-23 08:30AM
Apr-12-23 08:30AM
Apr-05-23 08:30AM
Mar-27-23 08:30AM
Mar-15-23 08:30AM
Mar-11-23 03:27AM
Mar-03-23 05:09AM
Feb-27-23 05:55PM
04:05PM
04:05PM
Feb-20-23 10:00AM
Feb-08-23 09:30AM
Jan-26-23 08:30AM
Jan-24-23 08:30AM
Jan-18-23 04:50PM
Jan-11-23 12:51PM
09:41AM
08:58AM
08:30AM
Dec-28-22 12:34PM
Dec-15-22 08:30AM
Dec-14-22 12:00PM
Dec-01-22 08:30AM
Nov-28-22 05:39AM
Nov-22-22 08:30AM
Nov-11-22 05:58AM
Nov-09-22 06:25PM
04:05PM
04:05PM
11:44AM
Nov-02-22 10:01AM
TTEC Holdings, Inc. is a digital global customer experience technology and services company. It focuses on the design, implementation, and delivery of transformative solutions for many brands. The firm operates through the following segments: TTEC Digital and TTEC Engage. The TTEC Digital segment provides design, build, and operate tech-enabled, insight-driven CX solutions. The TTEC Engage segment provides digitally-enabled customer care, acquisition, and fraud prevention services. The company was founded by Kenneth D. Tuchman in 1982 and is headquartered in Greenwood Village, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McLean Margaret BGC & CROApr 14 '24Option Exercise0.001,634054,757Apr 16 04:51 PM
Bourret FrancoisCHIEF ACCOUNTING OFFICERApr 14 '24Option Exercise0.001,19106,004Apr 16 04:44 PM
Bourret FrancoisCHIEF ACCOUNTING OFFICERMar 17 '24Option Exercise0.002,71805,832Mar 19 04:35 PM
Swanback Michelle RPRESIDENT, CEO, TTEC ENGAGEMar 16 '24Option Exercise0.0010,986019,672Mar 19 04:31 PM
McLean Margaret BGC & CROMar 04 '24Option Exercise0.00612052,306Mar 06 04:39 PM
McLean Margaret BGC & CROJul 01 '23Option Exercise0.003,239051,937Jul 05 04:55 PM
Bourret FrancoisINTERIM CFOJul 01 '23Option Exercise0.001,43103,236Jul 05 05:03 PM
Holtzman MarcDirectorJun 01 '23Buy32.323009,696300Jun 02 04:49 PM
Holtzman MarcDirectorMay 31 '23Buy31.407,960249,94333,229Jun 02 04:49 PM
Holtzman MarcDirectorMay 31 '23Buy31.211,17536,6711,425Jun 02 04:49 PM
Singh-Bushell EktaDirectorMay 24 '23Option Exercise0.001,990016,785May 26 04:48 PM
Conley Gregory ADirectorMay 24 '23Option Exercise0.001,990017,025May 26 04:51 PM
Frerichs Robert NDirectorMay 24 '23Option Exercise0.001,990018,150May 26 04:41 PM
Anenen StevenDirectorMay 24 '23Option Exercise0.001,990021,829May 26 04:45 PM
BAHL TRACY LDirectorMay 24 '23Option Exercise0.001,990017,935May 26 04:34 PM
Holtzman MarcDirectorMay 24 '23Option Exercise0.001,990025,269May 26 04:37 PM
LOFTEN GINADirectorMay 24 '23Option Exercise0.001,99004,195May 26 04:31 PM
Swanback Michelle RPRESIDENT, CEO, TTEC ENGAGEMay 02 '23Option Exercise0.0012,191012,191May 04 04:44 PM
Last Close
Apr 26 09:30AM ET
23.63
Dollar change
+0.20
Percentage change
0.85
%
KF The Korea Fund, Inc. daily Stock Chart
Index- P/E6.60 EPS (ttm)3.58 Insider Own6.77% Shs Outstand4.88M Perf Week2.78%
Market Cap115.27M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float4.55M Perf Month-6.86%
Income- PEG- EPS next Q- Inst Own70.76% Short Float0.22% Perf Quarter9.03%
Sales1.68M P/S68.71 EPS this Y- Inst Trans- Short Ratio0.52 Perf Half Y24.24%
Book/sh28.37 P/B0.83 EPS next Y- ROA- Short Interest0.01M Perf Year12.31%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range18.30 - 25.56 Perf YTD0.98%
Dividend Est.- P/FCF- EPS past 5Y0.00% ROI- 52W High-7.53% Beta1.18
Dividend TTM- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low29.13% ATR (14)0.37
Dividend Ex-DateDec 23, 2022 Current Ratio- EPS Y/Y TTM- Oper. Margin- RSI (14)44.76 Volatility1.44% 1.26%
Employees- Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q- Payout- Rel Volume0.04 Prev Close23.43
Sales Surprise- EPS Surprise- Sales Q/Q-50.30% Earnings- Avg Volume18.71K Price23.63
SMA20-2.06% SMA50-2.33% SMA2005.34% Trades Volume101 Change0.85%
Sep-27-23 04:00PM
Dec-16-22 10:10AM
Nov-25-22 11:18AM
Apr-14-22 03:29AM
Dec-17-21 08:23AM
11:58AM Loading…
Nov-30-21 11:58AM
Mar-02-21 04:20PM
Dec-24-20 01:05PM
Dec-18-20 04:05PM
Dec-03-20 04:05PM
Nov-30-20 04:05PM
Oct-14-20 04:05PM
Sep-30-20 04:05PM
Aug-28-20 07:11PM
04:05PM
04:05PM Loading…
Jun-02-20 04:05PM
May-29-20 04:05PM
Mar-23-20 04:56PM
Mar-02-20 04:39PM
Feb-28-20 04:05PM
Dec-13-19 04:05PM
Nov-29-19 04:05PM
Oct-17-19 04:05PM
Sep-24-19 04:15PM
Aug-29-19 04:05PM
May-30-19 04:05PM
Feb-28-19 04:05PM
Dec-14-18 04:05PM
Nov-29-18 04:05PM
Oct-17-18 04:05PM
04:05PM Loading…
Sep-27-18 04:05PM
Aug-29-18 04:05PM
May-30-18 04:05PM
Feb-28-18 04:05PM
Dec-15-17 04:05PM
Nov-29-17 04:00PM
Oct-31-17 04:00PM
Oct-11-17 04:00PM
Aug-29-17 04:00PM
Aug-07-17 07:19AM
May-30-17 04:15PM
04:00PM
May-24-17 08:01AM
Apr-26-17 01:48PM
Apr-18-17 08:51AM
Feb-28-17 04:00PM
Dec-21-16 11:55AM
Dec-16-16 05:04PM
Nov-29-16 04:00PM
Nov-16-16 04:30PM
Oct-24-16 12:00PM
Oct-17-16 04:00PM
Sep-26-16 04:00PM
Aug-29-16 04:00PM
May-31-16 04:00PM
Feb-29-16 04:00PM
Dec-18-15 04:00PM
Dec-01-15 07:19PM
Nov-30-15 04:00PM
Nov-02-15 04:00PM
Oct-15-15 04:00PM
Aug-28-15 04:00PM
May-29-15 04:00PM
Feb-27-15 04:00PM
Nov-28-14 01:00PM
Nov-24-14 10:55AM
Nov-03-14 04:00PM
Oct-30-14 10:50AM
Oct-27-14 12:51PM
Oct-20-14 04:00PM
Sep-12-14 07:00AM
Sep-02-14 04:00PM
Aug-29-14 04:00PM
04:00PM
Jul-30-14 04:00PM
May-30-14 04:00PM
May-06-14 02:55PM
Apr-08-14 02:35PM
Mar-26-14 04:00PM
Mar-02-14 07:00PM
Feb-28-14 04:00PM
Feb-25-14 11:00AM
Feb-20-14 04:32PM
Jan-30-14 04:00PM
Nov-29-13 04:00PM
Nov-01-13 04:00PM
Oct-16-13 12:05PM
Sep-10-13 04:00PM
Aug-30-13 04:00PM
May-29-13 04:00PM
May-13-13 11:46AM
Apr-02-13 12:46PM
Apr-01-13 04:00PM
Feb-28-13 07:00PM
Feb-27-13 04:00PM
Feb-26-13 04:15PM
Feb-04-13 11:48AM
Jan-30-13 04:00PM
Nov-30-12 04:00PM
Nov-06-12 04:10PM
The Korea Fund, Inc. is a closed-ended equity mutual fund launched and managed by Allianz Global Investors U.S. LLC. The fund invests in the public equity markets of Korea. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in growth stocks of companies. It employs fundamental analysis with a bottom-up stock picking approach, focusing on such factors as price-to-earnings ratios, dividend yields, and earnings-per-share growth to create its portfolio. The fund benchmarks the performance of its portfolio against the MSCI Korea 25/50 Index. It uses 'Grassroots Research' to make its investments. The Korea Fund, Inc. was formed on August 29, 1984 and is domiciled in the United States.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hu YanDirectorSep 26 '23Buy20.7250010,360500Sep 27 04:38 PM
Last Close
Apr 26 10:13AM ET
29.65
Dollar change
+0.34
Percentage change
1.15
%
SUPN Supernus Pharmaceuticals Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-0.00 Insider Own4.28% Shs Outstand54.72M Perf Week0.84%
Market Cap1.62B Forward P/E15.23 EPS next Y1.95 Insider Trans-4.84% Shs Float52.39M Perf Month-12.13%
Income1.32M PEG- EPS next Q0.26 Inst Own106.64% Short Float8.94% Perf Quarter3.22%
Sales607.52M P/S2.67 EPS this Y-30.39% Inst Trans1.11% Short Ratio12.04 Perf Half Y27.51%
Book/sh16.84 P/B1.76 EPS next Y18.94% ROA0.08% Short Interest4.68M Perf Year-19.33%
Cash/sh4.66 P/C6.37 EPS next 5Y1.69% ROE0.15% 52W Range21.99 - 38.09 Perf YTD2.44%
Dividend Est.- P/FCF14.68 EPS past 5Y-59.02% ROI0.14% 52W High-22.17% Beta1.02
Dividend TTM- Quick Ratio1.43 Sales past 5Y9.22% Gross Margin72.24% 52W Low34.82% ATR (14)1.16
Dividend Ex-Date- Current Ratio1.70 EPS Y/Y TTM-97.75% Oper. Margin2.21% RSI (14)41.81 Volatility3.92% 3.79%
Employees652 Debt/Eq0.05 Sales Y/Y TTM-8.95% Profit Margin0.22% Recom1.50 Target Price40.50
Option/ShortYes / Yes LT Debt/Eq0.04 EPS Q/Q-94.81% Payout0.00% Rel Volume0.59 Prev Close29.31
Sales Surprise5.99% EPS Surprise59.50% Sales Q/Q-1.80% EarningsFeb 27 AMC Avg Volume388.68K Price29.65
SMA20-5.07% SMA50-5.44% SMA2001.95% Trades Volume35,739 Change1.15%
Date Action Analyst Rating Change Price Target Change
Jan-03-23Resumed Jefferies Buy $44 → $45
Dec-01-21Resumed Jefferies Buy $40 → $44
Apr-13-21Upgrade Jefferies Hold → Buy $25 → $40
Jun-16-20Upgrade Piper Sandler Neutral → Overweight $25 → $31
Jun-15-20Resumed Jefferies Hold $24
Nov-08-19Downgrade Berenberg Buy → Hold
Nov-07-19Downgrade Stifel Buy → Hold $55 → $23
Nov-06-19Downgrade Jefferies Buy → Hold $46 → $23
Nov-12-18Reiterated B. Riley FBR Buy $68 → $65
Jan-18-18Reiterated B. Riley FBR, Inc. Buy $54
Apr-24-24 04:05PM
Apr-08-24 12:11PM
08:00AM
Mar-27-24 04:37PM
Mar-06-24 04:30PM
08:28PM Loading…
Mar-04-24 08:28PM
Feb-28-24 04:30PM
09:19AM
07:17AM
Feb-27-24 07:30PM
06:50PM
06:02PM
05:00PM
04:05PM
Feb-26-24 09:15AM
10:00AM Loading…
Feb-20-24 10:00AM
Feb-13-24 04:05PM
Feb-05-24 08:30AM
Dec-19-23 07:30AM
Dec-14-23 07:43PM
Nov-18-23 05:03AM
Nov-10-23 12:10PM
Nov-09-23 09:54AM
Nov-08-23 07:30PM
07:15PM
06:08PM
04:05PM
Nov-07-23 04:30PM
Nov-02-23 07:00AM
Nov-01-23 10:01AM
04:15PM Loading…
Oct-25-23 04:15PM
Oct-16-23 05:34PM
Oct-09-23 04:45PM
Sep-27-23 04:15PM
Sep-26-23 07:37PM
Sep-09-23 08:00PM
Aug-31-23 05:30PM
Aug-21-23 09:00AM
Aug-08-23 08:30PM
07:55PM
06:40PM
04:17PM
Jul-28-23 02:56PM
Jul-25-23 06:36AM
Jul-24-23 04:05PM
Jun-27-23 11:50AM
Jun-21-23 08:00PM
Jun-10-23 07:40AM
May-31-23 04:15PM
May-11-23 08:39AM
May-10-23 11:23AM
May-09-23 08:30PM
07:05PM
06:09PM
04:05PM
May-02-23 04:05PM
Apr-26-23 08:00PM
Apr-25-23 04:15PM
Apr-03-23 04:05PM
Mar-31-23 12:41PM
Mar-30-23 05:22PM
Mar-08-23 04:05PM
Mar-02-23 08:29PM
Mar-01-23 04:55PM
05:50AM
Feb-28-23 05:25PM
04:05PM
Feb-21-23 10:00AM
Feb-14-23 04:30PM
09:27AM
Feb-09-23 06:15PM
Jan-18-23 08:11AM
Jan-03-23 07:11AM
Dec-30-22 12:46AM
Dec-01-22 02:37PM
Nov-22-22 05:00PM
Nov-11-22 05:52AM
Nov-08-22 07:25PM
05:30PM
04:05PM
Oct-25-22 04:30PM
Oct-10-22 08:30AM
Sep-07-22 09:03AM
Aug-31-22 04:00PM
08:55AM
Aug-11-22 08:59AM
Aug-08-22 10:00AM
Aug-04-22 05:25PM
04:01PM
Jul-25-22 05:00PM
Jul-11-22 11:45AM
Jun-02-22 04:05PM
May-09-22 04:05PM
May-02-22 04:55PM
03:08PM
08:30AM
Apr-29-22 08:00PM
Apr-13-22 04:11PM
Apr-07-22 03:18PM
Apr-04-22 05:00PM
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005, and is headquartered in Rockville, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 21 '24Option Exercise25.3014,491366,62223,061Mar 25 05:00 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 21 '24Sale35.3114,491511,6778,570Mar 25 05:00 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 20 '24Option Exercise25.3040010,1208,970Mar 22 05:00 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 20 '24Sale35.3140014,1248,570Mar 22 05:00 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 19 '24Option Exercise25.3012,364312,80920,934Mar 21 05:01 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 19 '24Sale35.3112,364436,5738,570Mar 21 05:01 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 13 '24Option Exercise17.6162,3661,098,52344,686Mar 15 06:39 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 13 '24Sale33.7462,3662,104,2898,570Mar 15 06:39 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 12 '24Option Exercise12.983,88450,41412,454Mar 14 05:00 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMar 12 '24Sale32.993,884128,1338,570Mar 14 05:00 PM
Khattar Jack A.President, CEOFeb 28 '24Option Exercise0.0035,0000932,005Feb 29 05:00 PM
Mottola FrankSVP, Quality, GMP, Ops, ITFeb 28 '24Option Exercise0.0099008,239Feb 29 05:01 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOFeb 26 '24Option Exercise9.135,00045,65013,570Feb 28 05:01 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOFeb 26 '24Sale30.215,000151,0508,570Feb 28 05:01 PM
Martin Tami TillotsonSr. V.P., Regulatory AffairsJan 10 '24Option Exercise9.248,00073,92093,664Jan 12 05:00 PM
Martin Tami TillotsonSr. V.P., Regulatory AffairsJan 10 '24Sale27.918,000223,28085,664Jan 12 05:00 PM
Rubin JonathanSr. VP, Chief Medical OfficerDec 22 '23Option Exercise0.0060003,447Dec 26 05:01 PM
Khattar Jack A.President, CEODec 22 '23Option Exercise0.0025,0000892,463Dec 26 05:00 PM
NEWHALL CHARLES W IIIDirectorNov 16 '23Option Exercise9.247,45768,903119,589Nov 20 05:00 PM
NEWHALL CHARLES W IIIDirectorNov 16 '23Sale28.012,50070,025117,089Nov 20 05:00 PM
Hudson Frederick M.DirectorNov 15 '23Option Exercise9.247,45768,90342,324Nov 17 05:00 PM
Hudson Frederick M.DirectorNov 15 '23Sale28.509,093259,15033,231Nov 17 05:00 PM
Mottola FrankSVP, Quality, GMP, Ops, ITNov 14 '23Option Exercise9.242,00018,4806,791Nov 16 05:00 PM
Mottola FrankSVP, Quality, GMP, Ops, ITNov 14 '23Sale28.131,11031,2245,681Nov 16 05:00 PM
DEC TIMOTHY CSenior Vice-President & CFOOct 13 '23Option Exercise0.004,00007,000Oct 13 05:00 PM
Khattar Jack A.President, CEOSep 07 '23Option Exercise0.0035,0000884,267Sep 07 05:00 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOSep 07 '23Option Exercise0.002,50008,347Sep 07 05:00 PM
Martin Tami TillotsonSr. V.P., Regulatory AffairsAug 30 '23Option Exercise23.998,100194,31993,349Sep 01 05:00 PM
Martin Tami TillotsonSr. V.P., Regulatory AffairsAug 30 '23Sale32.008,100259,20085,249Sep 01 05:00 PM
Martin Tami TillotsonSr. V.P., Regulatory AffairsAug 25 '23Sale31.595,135162,21585,249Aug 29 05:00 PM
Khattar Jack A.President, CEOMay 11 '23Option Exercise0.0031,2500864,272May 12 05:00 PM
DEC TIMOTHY CSenior Vice-President & CFOMay 11 '23Option Exercise0.001,50003,359May 12 05:00 PM
Bhatt Padmanabh P.Sr. VP of IP, CSOMay 11 '23Option Exercise0.0075005,497May 12 05:00 PM
Last Close
Apr 26 10:13AM ET
59.94
Dollar change
+1.15
Percentage change
1.95
%
EXAS Exact Sciences Corp. daily Stock Chart
Index- P/E- EPS (ttm)-1.14 Insider Own1.04% Shs Outstand181.36M Perf Week-1.68%
Market Cap10.88B Forward P/E507.70 EPS next Y0.12 Insider Trans-5.34% Shs Float179.65M Perf Month-10.38%
Income-204.15M PEG- EPS next Q-0.48 Inst Own87.63% Short Float5.51% Perf Quarter-6.75%
Sales2.50B P/S4.35 EPS this Y19.50% Inst Trans-1.74% Short Ratio4.01 Perf Half Y-3.03%
Book/sh17.34 P/B3.46 EPS next Y112.98% ROA-3.00% Short Interest9.89M Perf Year-4.37%
Cash/sh4.28 P/C13.99 EPS next 5Y- ROE-6.60% 52W Range56.05 - 100.77 Perf YTD-18.98%
Dividend Est.- P/FCF340.77 EPS past 5Y4.59% ROI-3.63% 52W High-40.52% Beta1.26
Dividend TTM- Quick Ratio2.07 Sales past 5Y43.88% Gross Margin70.14% 52W Low6.94% ATR (14)3.05
Dividend Ex-Date- Current Ratio2.32 EPS Y/Y TTM67.92% Oper. Margin-12.20% RSI (14)39.06 Volatility4.44% 4.85%
Employees6600 Debt/Eq0.82 Sales Y/Y TTM19.93% Profit Margin-8.17% Recom1.32 Target Price90.49
Option/ShortYes / Yes LT Debt/Eq0.79 EPS Q/Q61.80% Payout- Rel Volume0.77 Prev Close58.79
Sales Surprise1.26% EPS Surprise36.16% Sales Q/Q16.98% EarningsMay 08 AMC Avg Volume2.47M Price59.94
SMA20-11.51% SMA50-5.38% SMA200-14.73% Trades Volume292,370 Change1.95%
Date Action Analyst Rating Change Price Target Change
Jan-02-24Upgrade The Benchmark Company Hold → Buy $91
Dec-14-23Initiated Guggenheim Buy $90
Dec-13-23Initiated Wolfe Research Outperform $95
Oct-10-23Upgrade Piper Sandler Neutral → Overweight $90
Sep-28-23Initiated Bernstein Outperform $83
Aug-02-23Downgrade The Benchmark Company Buy → Hold
May-10-23Upgrade Craig Hallum Hold → Buy $55 → $85
May-05-23Initiated UBS Neutral $73
Mar-09-23Upgrade Citigroup Neutral → Buy $70 → $90
Feb-10-23Downgrade Credit Suisse Outperform → Neutral $50 → $70
Apr-25-24 08:05PM
Apr-24-24 06:15PM
07:16AM
Apr-22-24 12:44PM
11:10AM
06:15PM Loading…
Apr-17-24 06:15PM
Apr-15-24 06:52AM
06:00AM
Apr-12-24 07:00AM
06:49AM
06:40AM
Apr-11-24 06:00AM
Apr-10-24 06:15PM
08:16AM
12:00AM
07:37AM Loading…
Apr-09-24 07:37AM
Apr-08-24 12:05PM
07:00AM
06:00AM
Apr-05-24 10:16AM
Apr-04-24 10:15AM
06:05AM
Apr-03-24 09:57AM
Apr-02-24 04:02PM
Mar-29-24 08:09AM
Mar-28-24 06:00AM
Mar-27-24 08:05AM
Mar-26-24 07:00AM
Mar-25-24 09:55AM
Mar-22-24 11:30AM
08:19AM Loading…
Mar-18-24 08:19AM
04:30AM
Mar-14-24 04:16PM
Mar-13-24 05:03PM
Mar-11-24 12:59AM
Mar-08-24 09:55AM
Mar-07-24 07:59AM
Mar-04-24 11:52PM
03:49PM
10:38AM
Mar-03-24 10:32AM
Feb-26-24 06:00AM
Feb-23-24 12:01PM
Feb-22-24 11:08AM
10:30AM
10:22AM
01:30AM
12:06AM
Feb-21-24 06:20PM
05:41PM
05:12PM
04:05PM
Feb-20-24 02:39AM
Feb-15-24 07:47AM
Feb-14-24 10:00AM
Feb-13-24 08:12PM
Feb-10-24 05:06PM
Feb-07-24 09:00AM
Feb-01-24 06:00AM
Jan-28-24 09:25AM
Jan-22-24 08:00AM
Jan-18-24 05:04AM
Jan-13-24 02:05PM
Jan-08-24 02:48PM
Jan-07-24 04:30PM
Jan-02-24 06:00AM
Dec-21-23 09:43AM
Dec-20-23 01:49PM
Dec-17-23 05:43AM
Dec-14-23 04:02AM
Dec-13-23 12:52PM
08:45AM
Dec-07-23 08:05AM
Dec-05-23 09:11AM
Dec-04-23 12:13PM
Dec-01-23 11:32AM
05:26AM
Nov-30-23 04:05PM
Nov-25-23 09:45AM
Nov-23-23 12:02PM
Nov-20-23 03:06PM
09:55AM
07:30AM
Nov-17-23 08:04PM
07:10AM
Nov-14-23 05:20AM
Nov-10-23 07:00AM
Nov-09-23 08:10PM
Nov-06-23 09:35AM
Nov-03-23 08:09PM
Nov-02-23 07:23PM
04:02PM
11:03AM
09:40AM
01:14AM
12:30AM
Nov-01-23 06:06PM
04:05PM
06:00AM
Oct-31-23 05:20PM
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Baranick BrianEVP, GM., Precision OncologyApr 02 '24Sale79.4392473,39313,171Apr 03 07:30 PM
Condella SarahEVP, Human ResourcesApr 01 '24Sale70.002,000140,00071,787Apr 03 07:30 PM
Condella SarahEVP, Human ResourcesMar 28 '24Sale70.002,000140,00073,787Apr 01 04:30 PM
Conroy Kevin TPresident and CEOMar 01 '24Sale59.328,271490,6361,299,496Mar 04 08:38 PM
LEVANGIE DANIEL JDirectorMar 01 '24Sale57.505,000287,50022,975Mar 04 08:42 PM
Cunningham EverettChief Commercial OfficerMar 01 '24Sale59.322,412143,08046,179Mar 04 08:38 PM
Elliott Jeffrey ThomasChief Financial OfficerMar 01 '24Sale59.322,412143,08010,933Mar 04 08:40 PM
Baranick BrianGen. Mgr., Precision OncologyMar 01 '24Sale59.322,323137,80014,095Mar 04 08:36 PM
ORVILLE JACOB AGeneral Manager, ScreeningMar 01 '24Sale59.322,154127,77514,324Mar 04 08:42 PM
Doyle James EdwardDirectorMar 01 '24Sale57.502,000115,00050,110Mar 04 08:39 PM
Condella SarahEVP, Human ResourcesMar 01 '24Sale59.321,724102,26875,787Mar 04 08:37 PM
Herriott JamesGeneral CounselMar 01 '24Sale59.3286251,1349,125Mar 04 08:41 PM
Herriott JamesGeneral CounselFeb 29 '24Option Exercise0.001,89009,987Mar 04 08:41 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 29 '24Option Exercise0.005,291013,345Mar 04 08:40 PM
Cunningham EverettChief Commercial OfficerFeb 29 '24Option Exercise0.005,291048,591Mar 04 08:38 PM
Conroy Kevin TPresident and CEOFeb 29 '24Option Exercise0.0018,14301,307,767Mar 04 08:38 PM
Baranick BrianGen. Mgr., Precision OncologyFeb 29 '24Option Exercise0.004,724016,418Mar 04 08:36 PM
Condella SarahEVP, Human ResourcesFeb 29 '24Option Exercise0.003,779077,511Mar 04 08:37 PM
ORVILLE JACOB AGeneral Manager, ScreeningFeb 29 '24Option Exercise0.004,724016,478Mar 04 08:42 PM
Conroy Kevin TPresident and CEOFeb 27 '24Sale56.896,263356,3021,289,624Feb 28 07:35 PM
Cunningham EverettChief Commercial OfficerFeb 27 '24Sale56.893,648207,53543,300Feb 28 07:37 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 27 '24Sale56.892,710154,1728,054Feb 28 07:36 PM
Baranick BrianGen. Mgr., Precision OncologyFeb 27 '24Sale56.892,027115,31611,694Feb 28 07:34 PM
Condella SarahEVP, Human ResourcesFeb 27 '24Sale56.891,880106,95373,732Feb 28 07:35 PM
ORVILLE JACOB AGeneral Manager, ScreeningFeb 27 '24Sale56.891,879106,89611,754Feb 28 07:38 PM
Herriott JamesGeneral CounselFeb 27 '24Sale56.8978444,6028,097Feb 28 07:38 PM
ORVILLE JACOB AGeneral Manager, ScreeningFeb 26 '24Option Exercise0.003,954013,633Feb 28 07:38 PM
Cunningham EverettChief Commercial OfficerFeb 26 '24Option Exercise0.007,678046,948Feb 28 07:37 PM
Herriott JamesGeneral CounselFeb 26 '24Option Exercise0.001,64808,881Feb 28 07:38 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 26 '24Option Exercise0.005,701010,764Feb 28 07:36 PM
Condella SarahEVP, Human ResourcesFeb 26 '24Option Exercise0.003,954075,612Feb 28 07:35 PM
Conroy Kevin TPresident and CEOFeb 26 '24Option Exercise0.0013,18101,295,887Feb 28 07:35 PM
Baranick BrianGen. Mgr., Precision OncologyFeb 26 '24Option Exercise0.003,954013,721Feb 28 07:34 PM
Conroy Kevin TPresident and CEOFeb 23 '24Option Exercise13.96102,8371,435,6051,344,266Feb 26 05:00 PM
Condella SarahEVP, Human ResourcesFeb 23 '24Sale59.721,02160,97471,658Feb 26 05:00 PM
Conroy Kevin TPresident and CEOFeb 22 '24Sale59.7811,565691,3561,241,429Feb 23 07:59 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 22 '24Sale59.781,35180,7635,063Feb 23 08:01 PM
Cunningham EverettChief Commercial OfficerFeb 22 '24Sale59.781,35080,70339,270Feb 23 08:00 PM
Baranick BrianGen. Mgr., Precision OncologyFeb 22 '24Sale59.781,09365,3409,767Feb 23 07:57 PM
ORVILLE JACOB AGeneral Manager, ScreeningFeb 22 '24Sale59.781,01360,5579,679Feb 23 08:03 PM
Condella SarahEVP, Human ResourcesFeb 22 '24Sale59.781,01360,55772,679Feb 23 07:57 PM
COWARD D SCOTTDirectorFeb 22 '24Sale59.7866339,63444,493Feb 23 07:59 PM
Herriott JamesGeneral CounselFeb 22 '24Sale59.7829117,3967,233Feb 23 08:02 PM
Conroy Kevin TPresident and CEOFeb 21 '24Sale61.504,975305,9621,229,756Feb 22 07:37 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 21 '24Sale61.501,49391,8203,703Feb 22 07:38 PM
Condella SarahEVP, Human ResourcesFeb 21 '24Sale61.501,07966,35871,658Feb 22 07:36 PM
ORVILLE JACOB AGeneral Manager, ScreeningFeb 21 '24Sale61.501,07866,2978,658Feb 22 07:40 PM
Baranick BrianGen. Mgr., Precision OncologyFeb 21 '24Sale61.5089555,0428,826Feb 22 07:36 PM
COWARD D SCOTTDirectorFeb 21 '24Sale61.5070643,41943,122Feb 22 07:38 PM
Herriott JamesGeneral CounselFeb 21 '24Sale61.5041525,5226,943Feb 22 07:39 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 20 '24Option Exercise0.003,11205,196Feb 22 07:38 PM
Conroy Kevin TPresident and CEOFeb 20 '24Option Exercise0.0010,37401,234,731Feb 22 07:37 PM
COWARD D SCOTTDirectorFeb 20 '24Option Exercise0.002,248043,828Feb 22 07:38 PM
Baranick BrianGen. Mgr., Precision OncologyFeb 20 '24Option Exercise0.001,72909,721Feb 22 07:36 PM
Condella SarahEVP, Human ResourcesFeb 20 '24Option Exercise0.002,248072,737Feb 22 07:36 PM
Herriott JamesGeneral CounselFeb 20 '24Option Exercise0.0086407,358Feb 22 07:39 PM
ORVILLE JACOB AGeneral Manager, ScreeningFeb 20 '24Option Exercise0.002,24809,736Feb 22 07:40 PM
Conroy Kevin TPresident and CEOFeb 15 '24Sale61.4314,791908,6111,224,357Feb 16 06:22 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 15 '24Sale61.431,888115,9802,084Feb 16 06:24 PM
COWARD D SCOTTDirectorFeb 15 '24Sale61.431,37684,52841,580Feb 16 06:23 PM
ORVILLE JACOB AGeneral Manager, ScreeningFeb 15 '24Sale61.4396659,3417,488Feb 16 06:26 PM
Condella SarahEVP, Human ResourcesFeb 15 '24Sale61.4396559,28070,489Feb 16 06:21 PM
Herriott JamesGeneral CounselFeb 15 '24Sale61.4342125,8626,494Feb 16 06:25 PM
Conroy Kevin TPresident and CEOFeb 14 '24Option Exercise0.0031,13301,239,148Feb 16 06:22 PM
Condella SarahEVP, Human ResourcesFeb 14 '24Option Exercise0.002,031071,454Feb 16 06:21 PM
Herriott JamesGeneral CounselFeb 14 '24Option Exercise0.0088306,915Feb 16 06:25 PM
ORVILLE JACOB AGeneral Manager, ScreeningFeb 14 '24Option Exercise0.002,03108,454Feb 16 06:26 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 14 '24Option Exercise0.003,97203,972Feb 16 06:24 PM
COWARD D SCOTTDirectorFeb 14 '24Option Exercise0.003,972042,956Feb 16 06:23 PM
Condella SarahEVP, Human ResourcesJan 02 '24Sale73.502,000147,00069,423Jan 04 05:19 PM
Baranick BrianGen. Mgr., Precision OncologyJan 02 '24Sale73.5087964,6067,992Jan 04 05:17 PM
Condella SarahEVP, Human ResourcesDec 14 '23Sale70.002,000140,00071,423Dec 18 07:49 PM
Cunningham EverettChief Commercial OfficerOct 12 '23Sale66.4913,007864,83537,909Oct 13 07:59 PM
Cunningham EverettChief Commercial OfficerOct 11 '23Option Exercise0.0027,504050,916Oct 13 07:59 PM
Condella SarahEVP, Human ResourcesSep 01 '23Sale84.364,500379,62075,814Sep 06 04:04 PM
Elliott Jeffrey ThomasChief Financial OfficerAug 21 '23Sale82.9230,2102,505,0130Aug 23 04:08 PM
Baranick BrianGen. Mgr., Precision OncologyAug 07 '23Sale85.041,350114,8048,871Aug 08 04:09 PM
Baranick BrianGen. Mgr., Precision OncologyAug 04 '23Option Exercise0.002,712010,221Aug 08 04:09 PM
Doyle James EdwardDirectorJul 27 '23Sale97.422,000194,84052,110Jul 28 04:06 PM
Herriott JamesGeneral CounselJul 19 '23Sale100.001,300130,0005,964Jul 21 04:04 PM
Zanotti Katherine SDirectorJun 09 '23Sale90.513,027273,97464,629Jun 12 04:17 PM
Doyle James EdwardDirectorJun 09 '23Sale90.511,402126,89554,110Jun 12 04:29 PM
Herriott JamesGeneral CounselJun 08 '23Sale90.001,300117,0007,264Jun 12 04:14 PM
Doyle James EdwardDirectorMay 26 '23Sale80.622,000161,24051,913May 31 04:13 PM
Condella SarahEVP, Human ResourcesMay 10 '23Sale80.006,087486,96080,314May 12 04:11 PM
ORVILLE JACOB AGeneral Manager, ScreeningMay 10 '23Sale80.005,000400,0006,423May 12 04:09 PM
Herriott JamesGeneral CounselMay 10 '23Sale79.851,300103,8058,564May 12 04:07 PM
Condella SarahEVP, Human ResourcesMay 01 '23Sale63.781,00063,78086,401May 03 04:04 PM
Last Close
Apr 26 10:13AM ET
50.17
Dollar change
+0.44
Percentage change
0.88
%
EZU iShares MSCI EMU ETF daily Stock Chart
CategoryGlobal or ExUS Equities - Broad / Regional Asset TypeEquities (Stocks) TagsEurope Return% 1Y11.16% Shs Outstand Perf Week2.96%
SponsorBlackrock (iShares) ETF Type TagsEurozone Return% 3Y3.11% Total Holdings233 Perf Month-2.18%
Fund Family Bond Type Tagsequity Return% 5Y7.19% AUM7.60B Perf Quarter5.84%
IndexMSCI EMU Index Average Maturity Tagsmid-large-cap Return% 10Y NAV% Perf Half Y23.33%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year8.90%
Active/Passive Quant Type Tags- Flows% 1M0.00% 52W Range40.15 - 51.46 Perf YTD5.75%
Dividend TTM1.21 (2.42%) ESG Type Tags- Flows% 3M1.91% 52W High-2.51% Beta1.07
Dividend Ex-DateDec 20, 2023 Dividend Type Sector/Theme Flows% YTD1.91% 52W Low24.97% ATR (14)0.60
Expense0.51% Structure Type Region Flows% 1Y RSI (14)55.06 Volatility1.09% 1.04%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.90 Prev Close49.73
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume2.28M Price50.17
SMA200.52% SMA500.84% SMA2008.85% Trades Volume319,685 Change0.88%
Feb-07-22 08:38PM
Feb-01-22 01:38PM
Jan-14-22 01:38PM
Jan-04-22 05:38PM
Dec-18-21 03:38AM
02:38PM Loading…
Dec-10-21 02:38PM
Feb-16-21 04:05PM
Oct-23-20 10:12AM
Jun-02-20 06:42AM
Apr-30-20 09:09AM
Mar-18-20 09:25AM
Mar-04-20 06:47PM
Feb-25-20 12:14PM
Feb-12-20 03:42PM
Feb-06-20 04:02PM
06:30AM Loading…
Feb-03-20 06:30AM
Jan-09-20 05:31PM
09:29AM
Dec-17-19 03:02PM
06:26AM
Dec-02-19 10:45AM
Nov-25-19 03:45PM
Nov-01-19 07:29AM
Oct-25-19 09:00PM
04:51PM
Oct-10-19 07:41AM
Oct-01-19 10:40AM
Sep-23-19 12:05PM
Sep-18-19 06:46AM
Sep-12-19 05:26PM
06:46AM Loading…
Aug-27-19 06:46AM
Aug-05-19 08:51AM
Jul-26-19 11:43AM
Jul-24-19 09:20AM
Jul-19-19 04:36PM
Jul-12-19 12:00PM
Jun-18-19 10:15AM
May-27-19 08:18AM
May-23-19 01:47PM
May-17-19 07:00AM
May-15-19 07:00AM
May-06-19 09:15AM
May-03-19 10:12AM
Apr-04-19 07:31AM
Mar-26-19 02:45PM
Mar-11-19 07:27AM
Mar-08-19 03:00PM
Mar-07-19 03:46PM
12:00PM
Feb-22-19 10:23AM
Feb-15-19 03:27PM
Feb-12-19 03:14PM
Feb-11-19 08:52AM
Feb-10-19 05:05PM
Feb-08-19 02:30PM
Jan-18-19 06:58AM
Jan-03-19 11:55AM
Dec-27-18 01:52PM
07:28AM
Dec-10-18 02:51PM
Dec-04-18 06:41AM
Oct-24-18 07:00AM
Sep-26-18 12:22PM
Aug-31-18 02:09PM
Aug-29-18 09:00AM
Aug-22-18 11:15AM
Aug-14-18 12:20PM
Jul-25-18 07:00AM
Jul-10-18 12:38PM
Jul-04-18 09:26AM
Jun-29-18 12:26PM
Jun-27-18 03:25PM
Jun-14-18 12:10PM
Jun-07-18 04:56PM
May-31-18 11:34AM
May-28-18 11:52PM
May-24-18 01:05PM
May-10-18 10:59AM
May-04-18 04:21PM
May-03-18 03:45PM
Apr-27-18 05:33PM
Apr-25-18 09:55AM
Apr-13-18 05:14PM
Apr-06-18 04:15PM
Mar-23-18 02:32PM
Feb-22-18 06:27PM
Jan-31-18 05:35PM
Jan-19-18 07:37AM
Jan-18-18 07:33AM
Jan-17-18 01:00PM
11:27AM
Jan-12-18 09:00AM
Jan-11-18 11:46AM
11:45AM
Jan-04-18 01:59PM
Dec-28-17 09:02AM
Dec-27-17 11:50AM
Dec-22-17 06:00AM
iShares MSCI Eurozone ETF seeks to track the investment results of the MSCI EMU Index composed of large- and mid-capitalization equities from developed market countries that use the euro as their official currency. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index consists of securities from the following 10 developed market countries: Austria, Belgium, Finland, France, Germany, Ireland, Italy, the Netherlands, Portugal and Spain.
Last Close
Apr 26 09:46AM ET
35.70
Dollar change
+0.63
Percentage change
1.79
%
EFNL iShares MSCI Finland ETF daily Stock Chart
CategoryGlobal or ExUS Equities - Country Specific Asset TypeEquities (Stocks) TagsFinland Return% 1Y-3.67% Shs Outstand Perf Week2.06%
SponsorBlackrock (iShares) ETF Type Tagsequity Return% 3Y-7.10% Total Holdings40 Perf Month0.86%
Fund Family Bond Type Tags- Return% 5Y1.68% AUM17.54M Perf Quarter0.36%
IndexMSCI Finland IMI 25/50 Index Average Maturity Tags- Return% 10Y NAV% Perf Half Y16.31%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year-7.22%
Active/Passive Quant Type Tags- Flows% 1M-23.19% 52W Range30.30 - 39.06 Perf YTD-0.28%
Dividend TTM1.54 (4.32%) ESG Type Tags- Flows% 3M-9.38% 52W High-8.60% Beta0.97
Dividend Ex-DateDec 20, 2023 Dividend Type Sector/Theme Flows% YTD-9.38% 52W Low17.82% ATR (14)0.43
Expense0.56% Structure Type Region Flows% 1Y RSI (14)57.03 Volatility0.81% 0.78%
Option/ShortNo / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.03 Prev Close35.07
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume7.30K Price35.70
SMA201.41% SMA502.14% SMA2004.25% Trades Volume27 Change1.79%
Feb-04-22 05:38PM
Dec-09-19 02:31AM
Apr-09-19 08:00AM
Feb-27-19 01:00PM
Jun-14-17 03:34PM
04:33PM Loading…
May-02-17 04:33PM
Apr-24-17 10:07AM
Dec-23-15 10:16AM
Nov-11-15 11:40AM
Oct-01-15 07:30AM
Sep-14-15 06:01AM
Jul-13-15 11:16AM
Apr-04-15 12:01AM
Mar-09-15 07:30AM
Mar-05-15 04:29PM
09:00AM Loading…
Jan-08-15 09:00AM
Dec-11-14 03:42PM
Nov-05-14 08:20AM
Aug-26-14 02:12PM
Aug-20-14 11:17AM
Jul-10-14 01:46PM
Jul-08-14 09:00AM
Apr-30-14 02:46PM
Jan-27-14 09:00AM
Jan-03-14 01:43PM
Dec-01-13 07:45AM
Nov-15-13 08:15AM
Nov-13-13 09:20AM
Oct-04-13 12:27PM
Sep-03-13 03:16PM
08:25AM Loading…
Jun-12-13 08:25AM
Mar-28-13 04:00AM
Sep-07-12 12:40PM
Sep-06-12 10:33AM
Jun-22-12 04:00AM
Jun-12-12 07:57AM
Jun-11-12 10:24AM
Jun-04-12 10:28AM
May-29-12 07:58AM
May-15-12 05:50PM
May-14-12 04:31PM
May-11-12 04:01PM
May-10-12 11:38AM
Apr-08-12 02:10AM
Feb-28-12 10:21AM
Feb-09-12 03:50PM
Feb-07-12 06:01PM
Feb-06-12 05:05PM
11:02AM
Feb-03-12 10:57AM
Jan-31-12 07:00AM
Jan-30-12 06:01PM
05:16PM
Jan-28-12 10:00AM
Jan-27-12 07:01AM
06:00AM
Jan-12-12 07:54PM
iShares MSCI Finland ETF seeks to track the investment results of the MSCI Finland IMI 25/50 Index. The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Finland. The underlying index uses a capping methodology that limits the weight of any single "group entity" to a maximum of 25% of the underlying index weight. The fund is non-diversified.